RHYTHM PHARMACEUTICALS, INC. ($RYTM)
Filing Information
| Accession Number | 0001649904-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
189,036
Total Value
$9,898,568.22
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Head of North America | Common Stock | โ | Aug 13, 2026 | Exercise/Conversion | 35,000 | $24.29 | $850,150.00 | 54,233 | Direct | โ | View Details | |
EVP, Head of North America | Common Stock | โ | Aug 13, 2026 | Exercise/Conversion | 21,601 | $6.80 | $146,886.80 | 75,834 | Direct | โ | View Details | |
EVP, Head of North America | Common Stock | โ | Aug 13, 2026 | Sale | 75,834 | $117.38 | $8,901,531.42 | 0 | Direct | โ | View Details | |
EVP, Head of North America | Stock Options (Right to Buy) | Derivative | Aug 13, 2026 | Exercise/Conversion | 35,000 | $0.00 | $0.00 | 36,283 | Direct | โ | View Details | |
EVP, Head of North America | Stock Options (Right to Buy) | Derivative | Aug 13, 2026 | Exercise/Conversion | 21,601 | $0.00 | $0.00 | 0 | Direct | โ | View Details |